Arthroniq is pleased to announce its qualification for the European Commission’s invest.eu platform, a significant achievement that opens new opportunities for growth and innovation in the healthcare technology sector.

The invest.eu platform serves as a key gateway for European companies seeking funding and support for innovative projects. Arthroniq’s acceptance represents recognition of our cutting-edge approach to personalized medical solutions and our potential to make a meaningful impact in the field of orthopedic surgery.

Platform Benefits

As a qualified participant in the invest.eu platform, Arthroniq will now have access to:

• Enhanced visibility among European investors and stakeholders
• Priority support for funding applications
• Networking opportunities with other innovative companies
• Access to specialized advisory services for business development

Strategic Importance

This qualification aligns with Arthroniq’s mission to revolutionize medical device design through personalized solutions. The invest.eu platform will help accelerate our efforts in bringing CHIDOS technology to market and expanding our reach across European healthcare systems.

For more information about the invest.eu platform, visit: European Commission invest.eu

Arthroniq’s participation in this prestigious program demonstrates our commitment to innovation and excellence in medical technology development. Our pitchbook and promotional materials will now be available through the official invest.eu platform for interested investors and partners.

About Arthroniq

Arthroniq is a leading developer of personalized medical solutions, specializing in the design and optimization of hip implants using advanced computational modeling and patient-specific biomechanics.